hopemax
Well-Known Member
One of them, I don't remember which one, already said that for their initial batch, there was an issue. A problem with the quality of product delivered by their original supplier, and so they had to roll back estimates of how many they could initially deliver. They say now they are on track with a new supplier, but is it something that the remaining vaccines that aren't as far along may have to negotiate.I wonder if supply chain issues might become a problem with multiple vaccines in production?
I also wonder, at what point do smaller countries start making noise about how many doses they are getting. I think Canada has already started agitating. So will the flow to the US slow down a little, after the high risk group to be a good global citizen?